Did you know?
ChinaBio® Group is an investment, consulting and media firm helping western life science companies achieve success in China. ChinaBio works with U.S., European and APAC companies seeking partnerships, acquisitions, novel technologies and funding in China.  

>> Learn more…

Site Search

>> Advanced Search

  Quick Search:
 
 

Free Newsletter

  Email address:
   

Shandong Jincheng Pharma Completes $72 Million IPO

publication date: Jun 22, 2011
View a Printer Friendly version of this page, allowing you to print the page. Send a summary of this page to someone via email.
Shandong Jincheng Pharmaceutical and Chemical completed a 465 million RMB ($72 million) IPO on Shenzhen’s ChiNext exchange. The company issued 25 million shares at 18.6 yuan each, a price that reflects a P/E ratio of 22.7. Jincheng Pharma makes cephalosporin intermediates. It plans to use the proceeds of the offering to expand its production capacity. More details....

Stock Symbol: (SHE: 300233)     Share this with colleagues:  

 


This article is available for purchase - please click here for details.


Sorry... this feature or article is only available to subscribers.

>> Learn more about our subscription plans...

>> Free email newsletter...

>> Login...

Login

  

    
   
Our Partners
Annual Sponsors
Official Partners
Supporting Partners
Media Sponsors